| AC | Adenocarcinoma |
| AIET | Autologous immune enhancement therapy |
| BIJ | Biotherapy Institute of Japan |
| BINKIT | Immune cell expansion kit of Biotherapy Institute of Japan |
| CD | Cluster of differentiation |
| CIK cells | Cytokine-induced killer cells |
| CTL | Cytotoxic T Lymphocyte |
| D | Day of culture |
| DC | Dendritic cell |
| ECOG/PS scale | Eastern Cooperative Oncology Group/Performance Status scale |
| EORTC QLQ-C30 | Organization for Research and Treatment of Cancer Quality of Life Questionnaire Version 3.0 |
| HCC | Hepatocellular carcinoma |
| IL | Interleukin |
| MHC | Major histocompatibility complex |
| NK cell | Natural killer cell |
| OS | Overall survival |
| PBMNC | Peripheral blood mononuclear cell |
| PT | Patient |
| QoL | Quality of life |
| SqC | Squamous cell carcinoma |
| TCR | T-cell receptors |
| VAFS | Visual analog fatigue scale |